Brody R, et al. PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature reviewLung Cancer. 2017;Oct;112:200-215.

Esposito AR, et al. The role of circulating free DNA in the management of NSCLCExpert Rev Anticancer Ther. 2018 Nov 21:1-10

Goodman AM, et al. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancersMol Cancer Ther. 2017; Nov;16(11):2598-2608.

Thakur MK, et al. Predictive and prognostic biomarkers in non-small cell lung cancerSemin Respir Crit Care Med. 2016;Oct;37(5):760-770.

Association of Community Cancer Centers Resources

Below are resources that include process improvement opportunities, case studies of effective practices, webinars, and practical tools developed by ACCC:

Our Partners



Our Supporter


This project is made possible by support from AstraZeneca.